165 related articles for article (PubMed ID: 18404716)
1. Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro.
Faucheux C; Verron E; Soueidan A; Josse S; Arshad MD; Janvier P; Pilet P; Bouler JM; Bujoli B; Guicheux J
J Biomed Mater Res A; 2009 Apr; 89(1):46-56. PubMed ID: 18404716
[TBL] [Abstract][Full Text] [Related]
2. Novel biomaterials for bisphosphonate delivery.
Josse S; Faucheux C; Soueidan A; Grimandi G; Massiot D; Alonso B; Janvier P; Laïb S; Pilet P; Gauthier O; Daculsi G; Guicheux JJ; Bujoli B; Bouler JM
Biomaterials; 2005 May; 26(14):2073-80. PubMed ID: 15576181
[TBL] [Abstract][Full Text] [Related]
3. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
[TBL] [Abstract][Full Text] [Related]
4. In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite.
Verron E; Gauthier O; Janvier P; Pilet P; Lesoeur J; Bujoli B; Guicheux J; Bouler JM
Biomaterials; 2010 Oct; 31(30):7776-84. PubMed ID: 20643480
[TBL] [Abstract][Full Text] [Related]
5. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
Schindeler A; Little DG
Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296
[TBL] [Abstract][Full Text] [Related]
6. Volumetric analysis of osteoclastic bioresorption of calcium phosphate ceramics with different solubilities.
Winkler T; Hoenig E; Gildenhaar R; Berger G; Fritsch D; Janssen R; Morlock MM; Schilling AF
Acta Biomater; 2010 Oct; 6(10):4127-35. PubMed ID: 20451677
[TBL] [Abstract][Full Text] [Related]
7. Bone substitute materials delivering zoledronic acid: physicochemical characterization, drug load, and release properties.
Sörensen TC; Arnoldi J; Procter P; Robioneck B; Steckel H
J Biomater Appl; 2013 Feb; 27(6):727-38. PubMed ID: 22090432
[TBL] [Abstract][Full Text] [Related]
8. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
[TBL] [Abstract][Full Text] [Related]
9. Interaction between a bisphosphonate, tiludronate and nanocrystalline apatite: in vitro viability and proliferation of HOP and HBMSC cells.
Pascaud P; Bareille R; Bourget C; Amédée J; Rey C; Sarda S
Biomed Mater; 2012 Oct; 7(5):054108. PubMed ID: 22972389
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion.
Miyazaki T; Miyauchi S; Anada T; Imaizumi H; Suzuki O
Anal Biochem; 2011 Mar; 410(1):7-12. PubMed ID: 21078287
[TBL] [Abstract][Full Text] [Related]
12. In vitro generation of mature human osteoclasts.
Hemingway F; Cheng X; Knowles HJ; Estrada FM; Gordon S; Athanasou NA
Calcif Tissue Int; 2011 Nov; 89(5):389-95. PubMed ID: 21960377
[TBL] [Abstract][Full Text] [Related]
13. The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro.
Greiner S; Kadow-Romacker A; Lübberstedt M; Schmidmaier G; Wildemann B
J Biomed Mater Res A; 2007 Mar; 80(4):769-75. PubMed ID: 17041912
[TBL] [Abstract][Full Text] [Related]
14. The response of dental pulp-derived cells to zoledronate depends on the experimental model.
Cvikl B; Agis H; Stögerer K; Moritz A; Watzek G; Gruber R
Int Endod J; 2011 Jan; 44(1):33-40. PubMed ID: 20812943
[TBL] [Abstract][Full Text] [Related]
15. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro.
Kadow-Romacker A; Greiner S; Schmidmaier G; Wildemann B
J Biomater Appl; 2013 Jan; 27(5):577-85. PubMed ID: 21862509
[TBL] [Abstract][Full Text] [Related]
16. [Degradation of electrodeposited calcium phosphate and calcium phosphate-chitosan coatings in vitro].
Wang LN; Wang YN; Wang JW
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Jun; 43(6):374-5. PubMed ID: 19031792
[TBL] [Abstract][Full Text] [Related]
17. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
Huang J; Yuan L; Wang X; Zhang TL; Wang K
Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
[TBL] [Abstract][Full Text] [Related]
18. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
19. Local co-application of zoledronate promotes long-term maintenance of newly formed bone induced by recombinant human bone morphogenetic protein 2.
Ichikawa K; Ohta Y; Mamoto K; Mizokawa S; Minoda Y; Imai Y; Takaoka K; Nakamura H
Biochem Biophys Res Commun; 2016 Nov; 480(3):314-320. PubMed ID: 27746180
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of zoledronate on the histomorphology of osteoclast in young albino rats.
Ralte S; Khatri K; Nagar M
Ann Anat; 2011 Dec; 193(6):509-15. PubMed ID: 21530208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
